Meiao Pharmaceutical Co., Ltd. has been recognized as a Shandong Province Gazelle Enterprise!
Recently, the Provincial Department of Industry and Information Technology announced the list of enterprises that have passed the recognition of Shandong Province Gazelle and Unicorn Enterprises 2024. Among them, Shandong Meiao Pharmaceutical Co., Ltd. successfully entered the list of “Gazelle” enterprises in the province! honor fully demonstrates the high recognition and support of Shandong Province for innovative and technological enterprises, and it is also a recognition of the professionalism of Shandong Mayo Co., Ltd. in the industry.
“Gazelle Enterprises” refers to excellent benchmark enterprises that have successfully crossed the start-up period, supported by new technologies, new, and new models, and steadily entered the high-growth period. They have outstanding comprehensive benefits, great industry influence, high social integrity, and strong demonstration and driving.
At present, the company has established a 1500-square-meter raw material research and development center in Jinan High-tech Zone. The company has a research and development team of more than 50 people, and the researchers come from domestic well-known schools such as Shandong University and China Pharmaceutical University, as well as well-known pharmaceutical enterprises. In addition, the company has established strategic relations with well-known institutions such as Shandong University, Fudan University, and East China Normal University.
With the concept and system of pharmaceutical research and development the company opened a cosmetics business department in 2020, forming the KTcos® cosmetics raw material product series, obtaining 12 patents, and applying 5 more. Among them, the production technology of KTcos® Pro-Xylane product “A production method of high-quality S-configuration Pro-Xylane color, taste, and borate” has been granted a national patent. The product has been tested by SGS to be colorless, tasteless, and free borate residue, reaching the leading level in the industry. In 2023, “KTcos® Pro-Xylane” won high-quality awards such asChina Cosmetics Association Innovation Achievement Award” and “China Chamber of Commerce Science and Technology First Prize”.
In March 2024, the “Cosmetics Raw Hydroxypropyl Tetrahydroxybutyrate” group standard edited by Shandong Mayo Pharmaceutical Co., Ltd. was officially released, which compensated for the separation degree of the main peak and impurities in the previous standard, and is currently the most perfect Pro-Xylane quality standard in the industry. Another advantage product Mayo Pharmaceutical, KTcos® Ectoin, has been granted a national patent “A recombinant strain for producing Ectoin and its construction method and application which uses the optimal recombinant strain as a biocatalyst for whole-cell conversion, greatly improving the yield of tetrahydroxybutyrate, and the stable and efficient synthesis of Ectoin.
Mayo Pharmaceutical always regards quality control as the first indicator in the research and development process. Adopting a holistic approach manage the commercial life cycle, regularly reviewing manufacturing processes and conducting performance trend analysis, continuously reducing costs, optimizing processes, and improving efficiency.
Proxylane pure
Supplying pure powder of Bosein ,proxylane
